Evidence map›Paper›PMID 36727249›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region].

R J Zheng, Tangnuer Talafu, Z R Deng, D Han, K J Pan, X B Lu

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. [Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  2. [Current status of diagnosis and treatment and progress in drug research and development for hepatitis D].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

R J ZhengInfectious Diseases and Hepatology Department of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Infectious Disease (Viral Hepatitis) Clinical Medical Research Center, Urumqi 830000, China.
Tangnuer TalafuInfectious Diseases and Hepatology Department of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Infectious Disease (Viral Hepatitis) Clinical Medical Research Center, Urumqi 830000, China.
Z R DengInfectious Diseases and Hepatology Department of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Infectious Disease (Viral Hepatitis) Clinical Medical Research Center, Urumqi 830000, China.
D HanInfectious Diseases and Hepatology Department of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Infectious Disease (Viral Hepatitis) Clinical Medical Research Center, Urumqi 830000, China.
K J PanInfectious Diseases and Hepatology Department of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Infectious Disease (Viral Hepatitis) Clinical Medical Research Center, Urumqi 830000, China.
X B LuInfectious Diseases and Hepatology Department of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Infectious Disease (Viral Hepatitis) Clinical Medical Research Center, Urumqi 830000, China.
Xinjiang Medical University · CN

Funding

National Natural Science Foundation of China 82060115
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis BHepatitis DBiomarkersChinaCross-Sectional StudiesHematologic TestsHepatitis AntibodiesHepatitis AntigensHepatitis B, ChronicHepatitis B Surface AntigensHepatitis B virusHepatitis Delta VirusHumansRNA, ViralSeroepidemiologic StudiesViral LoadBiomarkersHepatitis AntibodiesHepatitis AntigensHepatitis B Surface AntigensRNA, Viral

Identifiers

PMID36727249
PMCPMC12770657
OpenAlexW4318926220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.